Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Mark Breidenbach's Stock Ratings
Oppenheimer Analyst
Mark Breidenbach is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
0.04%
Smart Score
Overall Average Return Percentile
34th
Number of Ratings
87
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/01/2025 | ALLO | Buy Now | Allogene Therapeutics | $1.53 | 356.44% | $9 → $7 | Maintains | Outperform | Get Alert | |
| 09/04/2024 | NRIX | Buy Now | Nurix Therapeutics | $19.25 | 55.84% | $27 → $30 | Maintains | Outperform | Get Alert | |
| 08/14/2024 | NRIX | Buy Now | Nurix Therapeutics | $19.25 | 40.26% | $25 → $27 | Maintains | Outperform | Get Alert | |
| 05/21/2024 | ALLO | Buy Now | Allogene Therapeutics | $1.53 | 747.68% | $14 → $13 | Maintains | Outperform | Get Alert | |
| 12/13/2023 | EPIX | Buy Now | ESSA Pharma | — | — | → $17 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/11/2023 | ALPN | Buy Now | Alpine Immune Sciences | — | — | $14 → $22 | Maintains | Outperform | Get Alert | |
| 08/09/2023 | ARVN | Buy Now | Arvinas | $12.28 | 673.62% | $95 → $95 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/09/2023 | EPIX | Buy Now | ESSA Pharma | — | — | → $17 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/08/2023 | IMRX | Buy Now | Immuneering | $5.78 | 332.53% | → $25 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/03/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.53 | 1725.77% | → $28 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/26/2023 | ARVN | Buy Now | Arvinas | $12.28 | 673.62% | $95 → $95 | Assumes | → Outperform | Get Alert | |
| 06/26/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.53 | 1725.77% | → $28 | Assumes | → Outperform | Get Alert | |
| 06/26/2023 | ALPN | Buy Now | Alpine Immune Sciences | — | — | → $14 | Assumes | → Outperform | Get Alert | |
| 06/26/2023 | CUE | Buy Now | Cue Biopharma | $0.47 | 2032.65% | → $10 | Assumes | Outperform → Outperform | Get Alert | |
| 06/26/2023 | EPIX | Buy Now | ESSA Pharma | — | — | → $17 | Assumes | → Outperform | Get Alert | |
| 06/26/2023 | IMRX | Buy Now | Immuneering | $5.78 | 332.53% | → $25 | Assumes | → Outperform | Get Alert | |
| 06/26/2023 | MCRB | Buy Now | Seres Therapeutics | $17.00 | -29.41% | → $12 | Assumes | → Outperform | Get Alert | |
| 06/26/2023 | NRIX | Buy Now | Nurix Therapeutics | $19.25 | 29.87% | → $25 | Assumes | → Outperform | Get Alert | |
| 05/25/2023 | BLRX | Buy Now | BioLine Rx | $3.23 | 23.84% | → $4 | Reiterates | → Outperform | Get Alert | |
| 05/16/2023 | GMDA | Buy Now | Gamida Cell | — | — | $8 → $6 | Maintains | Outperform | Get Alert | |
| 05/16/2023 | CGEN | Buy Now | Compugen | $1.49 | 369.8% | $8 → $7 | Maintains | Outperform | Get Alert | |
| 05/08/2023 | ARVN | Buy Now | Arvinas | $12.28 | 673.62% | $95 → $95 | Reiterates | → Outperform | Get Alert | |
| 03/28/2023 | GMDA | Buy Now | Gamida Cell | — | — | $10 → $8 | Maintains | Outperform | Get Alert | |
| 03/24/2023 | ALPN | Buy Now | Alpine Immune Sciences | — | — | → $14 | Reiterates | → Outperform | Get Alert | |
| 03/22/2023 | CUE | Buy Now | Cue Biopharma | $0.47 | 2032.65% | → $10 | Reiterates | → Outperform | Get Alert | |
| 03/10/2023 | CRBU | Buy Now | Caribou Biosciences | $1.72 | 1760.47% | $36 → $32 | Maintains | Outperform | Get Alert | |
| 03/03/2023 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | 2599900% | $15 → $13 | Maintains | Outperform | Get Alert | |
| 03/01/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $2.15 | 597.67% | $25 → $15 | Maintains | Outperform | Get Alert | |
| 03/01/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.53 | 1725.77% | $32 → $28 | Maintains | Outperform | Get Alert | |
| 02/28/2023 | CGEN | Buy Now | Compugen | $1.49 | 436.91% | → $8 | Reiterates | → Outperform | Get Alert | |
| 02/28/2023 | NRIX | Buy Now | Nurix Therapeutics | $19.25 | 29.87% | → $25 | Initiates | → Outperform | Get Alert | |
| 11/15/2022 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | 2999900% | $30 → $15 | Maintains | Outperform | Get Alert | |
| 11/15/2022 | GMDA | Buy Now | Gamida Cell | — | — | $15 → $10 | Maintains | Outperform | Get Alert | |
| 11/15/2022 | CGEN | Buy Now | Compugen | $1.49 | 436.91% | $12 → $8 | Maintains | Outperform | Get Alert | |
| 10/25/2022 | ALPN | Buy Now | Alpine Immune Sciences | — | — | $17 → $14 | Maintains | Outperform | Get Alert | |
| 10/18/2022 | SYBX | Buy Now | Synlogic | $1.14 | 601.75% | $6 → $8 | Maintains | Outperform | Get Alert | |
| 09/02/2022 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 08/24/2022 | CUE | Buy Now | Cue Biopharma | $0.47 | 2032.65% | $26 → $10 | Maintains | Outperform | Get Alert | |
| 08/10/2022 | ALLO | Buy Now | Allogene Therapeutics | $1.53 | 2182.21% | $40 → $35 | Maintains | Outperform | Get Alert | |
| 08/10/2022 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | 599900% | $9 → $3 | Maintains | Outperform | Get Alert | |
| 08/08/2022 | CGEN | Buy Now | Compugen | $1.49 | 705.37% | $14 → $12 | Maintains | Outperform | Get Alert | |
| 08/08/2022 | ARVN | Buy Now | Arvinas | $12.28 | 730.62% | $108 → $102 | Maintains | Outperform | Get Alert | |
| 05/27/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $2.15 | 1155.81% | $31 → $27 | Maintains | Outperform | Get Alert | |
| 05/13/2022 | SYBX | Buy Now | Synlogic | $1.14 | 426.32% | $7 → $6 | Maintains | Outperform | Get Alert | |
| 04/01/2022 | IMRX | Buy Now | Immuneering | $5.78 | 332.53% | → $25 | Initiates | → Outperform | Get Alert | |
| 03/21/2022 | CUE | Buy Now | Cue Biopharma | $0.47 | 5444.89% | $32 → $26 | Maintains | Outperform | Get Alert | |
| 02/25/2022 | CGEN | Buy Now | Compugen | $1.49 | 839.6% | $17 → $14 | Maintains | Outperform | Get Alert | |
| 02/24/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | $92 → $86 | Maintains | Outperform | Get Alert | |
| 12/01/2021 | CRBU | Buy Now | Caribou Biosciences | $1.72 | 1993.02% | → $36 | Initiates | → Outperform | Get Alert | |
| 11/24/2021 | SYBX | Buy Now | Synlogic | $1.14 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 11/16/2021 | GMDA | Buy Now | Gamida Cell | — | — | $17 → $15 | Maintains | Outperform | Get Alert | |
| 08/17/2021 | EPIX | Buy Now | ESSA Pharma | — | — | $36 → $22 | Maintains | Outperform | Get Alert | |
| 07/23/2021 | MCRB | Buy Now | Seres Therapeutics | $17.00 | 5.88% | $36 → $18 | Maintains | Outperform | Get Alert | |
| 07/23/2021 | ARVN | Buy Now | Arvinas | $12.28 | 779.48% | $100 → $108 | Maintains | Outperform | Get Alert | |
| 07/19/2021 | KDMN | Buy Now | Kadmon Holdings | — | — | $8 → $9 | Maintains | Outperform | Get Alert | |
| 05/24/2021 | IOVA | Buy Now | Iovance Biotherapeutics | $2.15 | 1667.44% | $51 → $38 | Maintains | Outperform | Get Alert | |
| 05/19/2021 | IOVA | Buy Now | Iovance Biotherapeutics | $2.15 | 2272.09% | $57 → $51 | Maintains | Outperform | Get Alert | |
| 04/26/2021 | ACHL | Buy Now | Achilles Therapeutics | — | — | → $23 | Initiates | → Outperform | Get Alert | |
| 05/20/2020 | CUE | Buy Now | Cue Biopharma | $0.47 | 6724.48% | $27 → $32 | Maintains | Outperform | Get Alert | |
| 05/12/2020 | MBIO | Buy Now | Mustang Bio | $1.12 | 1060.71% | $15 → $13 | Maintains | Outperform | Get Alert | |
| 05/12/2020 | ARVN | Buy Now | Arvinas | $12.28 | — | — | Initiates | → Perform | Get Alert | |
| 05/07/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | $88 → $101 | Maintains | Outperform | Get Alert | |
| 03/31/2020 | MCRB | Buy Now | Seres Therapeutics | $17.00 | -58.82% | $8 → $7 | Maintains | Outperform | Get Alert | |
| 02/26/2020 | IOVA | Buy Now | Iovance Biotherapeutics | $2.15 | 1527.91% | $32 → $35 | Reiterates | → Outperform | Get Alert | |
| 02/25/2020 | CUE | Buy Now | Cue Biopharma | $0.47 | 5658.16% | → $27 | Initiates | → Outperform | Get Alert | |
| 12/13/2019 | BLUE | Buy Now | bluebird bio | — | — | → $135 | Upgrade | Perform → Outperform | Get Alert | |
| 10/25/2019 | EPIX | Buy Now | ESSA Pharma | — | — | → $8 | Initiates | → Outperform | Get Alert | |
| 08/21/2019 | SYBX | Buy Now | Synlogic | $1.14 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 06/26/2019 | KDMN | Buy Now | Kadmon Holdings | — | — | → $6 | Initiates | → Outperform | Get Alert | |
| 05/08/2018 | GBT | Buy Now | Global Blood Therapeutics | — | — | $79 → $74 | Maintains | Outperform | Get Alert | |
| 03/29/2018 | CGEN | Buy Now | Compugen | $1.49 | 504.03% | → $9 | Initiates | → Outperform | Get Alert | |
| 01/31/2018 | IOVA | Buy Now | Iovance Biotherapeutics | $2.15 | 783.72% | $13 → $19 | Maintains | Outperform | Get Alert | |
| 12/21/2017 | MBIO | Buy Now | Mustang Bio | $1.12 | 1507.14% | → $18 | Initiates | → Outperform | Get Alert | |
| 12/21/2017 | BLUE | Buy Now | bluebird bio | — | — | — | Initiates | → Perform | Get Alert | |
| 12/13/2017 | ADRO | Buy Now | Aduro Biotech | — | — | $15 → $13 | Maintains | Outperform | Get Alert | |
| 11/15/2017 | SRNE | Buy Now | Sorrento Therapeutics | $0.00 | 153746.15% | $7 → $6 | Maintains | Outperform | Get Alert | |
| 10/13/2017 | MCRB | Buy Now | Seres Therapeutics | $17.00 | 11.76% | → $19 | Initiates | → Outperform | Get Alert | |
| 08/04/2017 | SRNE | Buy Now | Sorrento Therapeutics | $0.00 | 179387.18% | → $7 | Initiates | → Outperform | Get Alert | |
| 08/04/2017 | IOVA | Buy Now | Iovance Biotherapeutics | $2.15 | 504.65% | → $13 | Initiates | → Outperform | Get Alert | |
| 08/04/2017 | GBT | Buy Now | Global Blood Therapeutics | — | — | → $53 | Initiates | → Outperform | Get Alert | |
| 04/20/2017 | MATN | Buy Now | Mateon Therapeutics | — | — | → $2 | Initiates | → Buy | Get Alert | |
| 02/01/2016 | CGEN | Buy Now | Compugen | $1.49 | — | — | Assumes | — | Get Alert | |
| 12/01/2015 | ADRO | Buy Now | Aduro Biotech | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 10/20/2015 | ADRO | Buy Now | Aduro Biotech | — | — | → $30 | Initiates | → Outperform | Get Alert | |
| 10/20/2015 | BLUE | Buy Now | bluebird bio | — | — | → $162 | Initiates | → Outperform | Get Alert | |
| 10/19/2015 | ADRO | Buy Now | Aduro Biotech | — | — | → $30 | Initiates | → Outperform | Get Alert | |
| 04/21/2015 | CGEN | Buy Now | Compugen | $1.49 | 638.26% | → $11 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved